Literature DB >> 4169437

Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels.

C G Cochrane, D Hawkins.   

Abstract

The relationship between certain physicochemical properties of circulating immune complexes and their ability to localize in vessel walls during a state of increased permeability was studied. The ability to become deposited was related to the large size of complexes, rather than to their net charge or to a specific affinity between complexes and structures of vessel walls. Soluble complexes with sedimentation rates greater than 19S were capable of being entrapped along the vessel wall membranes, while complexes smaller than this were not. These large complexes were removed rapidly from the circulation, while smaller complexes persisted. Minimal levels of total complexes in the circulation necessary for detectable vascular localization were found to be as low as 15 microg antibody N/ml plasma. In experimental serum sickness, a disease known to be induced by circulating immune complexes, the development of vascular and glomerular lesions occurred almost exclusively in rabbits having large (greater than 19S) circulating immune complexes. Animals with smaller complexes did not show deposition of complexes in glomeruli or development of glomerulonephritis. Their incidence of vasculitis was markedly reduced.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4169437      PMCID: PMC2138438          DOI: 10.1084/jem.127.1.137

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  GUINEA PIG BETA-1C-GLOBULIN: ITS RELATIONSHIP TO THE THIRD COMPONENT OF COMPLEMENT AND ITS ALTERATION FOLLOWING INTERACTION WITH IMMUNE COMPLEXES.

Authors:  W D LINSCOTT; C G COCHRANE
Journal:  J Immunol       Date:  1964-12       Impact factor: 5.422

2.  Immunoelectrophoretic studies on serum proteins. I. The antigens of human serum.

Authors:  C A WILLIAMS; P GRABAR
Journal:  J Immunol       Date:  1955-02       Impact factor: 5.422

3.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

4.  Possible relationship of rheumatoid factors and pulmonary disease.

Authors:  T B TOMASI; H H FUDENBERG; N FINBY
Journal:  Am J Med       Date:  1962-08       Impact factor: 4.965

5.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

6.  Diagnostic complement fixation. I. A method.

Authors:  A G OSLER; J H STRAUSS; M M MAYER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-03

7.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

8.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

9.  The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.

Authors:  W T Kniker; C G Cochrane
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

10.  STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS. I. STRUCTURAL STUDIES.

Authors:  C G COCHRANE
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

View more
  59 in total

1.  The mesangium in glomerular disease.

Authors:  J R Tighe
Journal:  Proc R Soc Med       Date:  1975-03

2.  Attempts to induce immune-mediated cerebral arterial injury for an experimental model of moyamoya disease.

Authors:  M Ezura; S Fujiwara; M Nose; T Yoshimoto; M Kyogoku
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

3.  Evidence for the involvement of IgE-basophil system in acute serum sickness.

Authors:  J Benveniste; J Egido; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Chronic immune complex disease in mice: the role of antibody affinity.

Authors:  M W Steward
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

5.  Dominant suppression of inflammation by glycan-hydrolyzed IgG.

Authors:  Kutty Selva Nandakumar; Mattias Collin; Kaisa E Happonen; Allyson M Croxford; Susanna L Lundström; Roman A Zubarev; Merrill J Rowley; Anna M Blom; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

6.  Glomerular lesions induced in the rabbit by physicochemically altered homologous IgG.

Authors:  F Cavalot; M Miyata; A Vladutiu; V Terranova; S Dubiski; R Burlingame; E Tan; J Brentjens; F Milgrom; G Andres
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

7.  Hereditary angio-oedema with mesangiocapillary glomerulonephritis.

Authors:  J Plaza; P Malasit; D N Kerr
Journal:  Postgrad Med J       Date:  1977-10       Impact factor: 2.401

8.  The influence of genotype on the development of glomerular lesions in mink with Aleutian disease virus.

Authors:  M I Johnson; J B Henson; J R Gorham
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

9.  [Circulating immune complexes in bronchogenic carcinoma: relation to extent of disease and to therapy (author's transl)].

Authors:  C Gropp; K Havemann; T Schärfe; H Schultz; E Schaumlöffel
Journal:  Klin Wochenschr       Date:  1979-04-17

10.  Experimental renal disease induced by DNA-anti-DNA immune complexes.

Authors:  P G Natali; E M Tan
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.